BRPI0810215A2 - Métodos e composições para contribuição para o tratamento de câncer - Google Patents

Métodos e composições para contribuição para o tratamento de câncer

Info

Publication number
BRPI0810215A2
BRPI0810215A2 BRPI0810215-5A2A BRPI0810215A BRPI0810215A2 BR PI0810215 A2 BRPI0810215 A2 BR PI0810215A2 BR PI0810215 A BRPI0810215 A BR PI0810215A BR PI0810215 A2 BRPI0810215 A2 BR PI0810215A2
Authority
BR
Brazil
Prior art keywords
contribution
compositions
methods
cancer treatment
cancer
Prior art date
Application number
BRPI0810215-5A2A
Other languages
English (en)
Inventor
Anil Gulati
Reddy Guru
Luigi Lenaz
Original Assignee
Spectrum Pharmaceuticals Inc
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc, Univ Illinois filed Critical Spectrum Pharmaceuticals Inc
Publication of BRPI0810215A2 publication Critical patent/BRPI0810215A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0810215-5A2A 2007-04-13 2008-04-10 Métodos e composições para contribuição para o tratamento de câncer BRPI0810215A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91177307P 2007-04-13 2007-04-13
PCT/US2008/059949 WO2008127996A1 (en) 2007-04-13 2008-04-10 Methods and compositions for contributing to the treatment of cancers

Publications (1)

Publication Number Publication Date
BRPI0810215A2 true BRPI0810215A2 (pt) 2014-10-21

Family

ID=39521878

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810215-5A2A BRPI0810215A2 (pt) 2007-04-13 2008-04-10 Métodos e composições para contribuição para o tratamento de câncer

Country Status (16)

Country Link
EP (1) EP2144607B1 (pt)
JP (1) JP5503528B2 (pt)
KR (1) KR20100016392A (pt)
CN (1) CN101686960A (pt)
AR (1) AR066048A1 (pt)
BR (1) BRPI0810215A2 (pt)
CA (1) CA2683890C (pt)
DK (1) DK2144607T3 (pt)
ES (1) ES2453295T3 (pt)
HK (1) HK1140145A1 (pt)
IL (1) IL201502A (pt)
MX (1) MX2009011041A (pt)
RU (1) RU2009141845A (pt)
TW (1) TWI439266B (pt)
WO (1) WO2008127996A1 (pt)
ZA (1) ZA200907083B (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1729012B (zh) * 2002-10-24 2013-05-22 伊利诺伊大学评议会 治疗实体瘤的组合物
JP2008531589A (ja) * 2005-02-22 2008-08-14 スペクトラム・ファーマシューティカルス・インコーポレーテッド 固形腫瘍の治療に貢献するための方法、組成物及び製品

Also Published As

Publication number Publication date
KR20100016392A (ko) 2010-02-12
AU2008240300A1 (en) 2008-10-23
JP5503528B2 (ja) 2014-05-28
TWI439266B (zh) 2014-06-01
AR066048A1 (es) 2009-07-22
ES2453295T3 (es) 2014-04-07
JP2010523697A (ja) 2010-07-15
EP2144607B1 (en) 2014-01-08
CA2683890C (en) 2020-01-07
TW200904404A (en) 2009-02-01
CA2683890A1 (en) 2008-10-23
ZA200907083B (en) 2011-01-26
CN101686960A (zh) 2010-03-31
IL201502A0 (en) 2010-05-31
IL201502A (en) 2017-01-31
RU2009141845A (ru) 2011-05-20
WO2008127996A1 (en) 2008-10-23
DK2144607T3 (da) 2014-04-07
EP2144607A1 (en) 2010-01-20
HK1140145A1 (en) 2010-10-08
MX2009011041A (es) 2009-11-19

Similar Documents

Publication Publication Date Title
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI1008566A8 (pt) métodos e composições para o diagnóstico e tratamento de câncer
BRPI0908854A2 (pt) composições e métodos para o tratamento de tumor de origem hematopoética
BRPI1008564A2 (pt) métodos e composições para o dignóstico e tratamento de câncer
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
DK2121139T3 (da) Formulations for cancer treatment
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0821660A2 (pt) Combinações de agentes terapêuticos para tratamento de câncer
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI1010874A8 (pt) composição para o tratamento de câncer de próstata
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI0911112A2 (pt) composições e métodos para o tratamento do câncer de mama
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
BRPI0812932A2 (pt) Composições e métodos de tratar câncer
BRPI0815330A2 (pt) métodos e composições para tratar cânceres

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]